Provided by Tiger Fintech (Singapore) Pte. Ltd.

Dr Reddy's Laboratories

12.36
-0.8800-6.65%
Post-market: 12.360.00000.00%17:35 EDT
Volume:3.93M
Turnover:49.10M
Market Cap:10.30B
PE:16.44
High:12.84
Open:12.71
Low:12.36
Close:13.24
Loading ...

Asian Equities Traded in the US as American Depositary Receipts Fall in Thursday Trading

MT Newswires Live
·
03 Apr

Dr. Reddy's Signs Commercialization, License Deals for Bio-Thera Biosimilars in Southeast Asia

MT Newswires Live
·
28 Mar

Bio-Thera and Dr. Reddy's Execute Exclusive Commercialization Agreement for BAT2206, a Proposed Stelara® Biosimilar, and BAT2506, a Proposed Simponi® Biosimilar, for Southeast Asia

PR Newswire
·
27 Mar

Asian Equities Traded in the US as American Depositary Receipts Higher in Thursday Trading

MT Newswires Live
·
27 Mar

Dr. Reddy's Laboratories Currently Up Eight Consecutive Days, on Track for Longest Winning Streak Since March 2019 -- Data Talk

Dow Jones
·
25 Mar

Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
20 Mar

FDA Accepts RDY & ALVO's Prolia & Xgeva Biosimilar BLA for Review

Zacks
·
19 Mar

Asian Equities Traded in the US as American Depositary Receipts Track Sharply Lower in Tuesday Trading

MT Newswires Live
·
18 Mar

Dr. Reddy's, Alvotech Say FDA Accepts Biologic License Application for Bone Drug Biosimilar

MT Newswires Live
·
18 Mar

Dr. Reddy’s, Alvotech announce FDA acceptance of BLA for AVT03

TIPRANKS
·
18 Mar

Alvotech and Dr. Reddy’s Announce FDA acceptance of Biologic License Application for AVT03, a Proposed Biosimilar to Prolia® and Xgeva®

GlobeNewswire
·
18 Mar

Asian Equities Traded in the US as American Depositary Receipts Open Week Sharply Higher

MT Newswires Live
·
17 Mar

Dr. Reddy's Laboratories Recalls Batch of Levetiracetam in 0.75% Sodium Chloride Injection in US

MT Newswires Live
·
13 Mar

Dr. Reddy’s announces recall of Levetiracetam 0.75% Sodium Chloride injection

TIPRANKS
·
13 Mar

Morgans Remains a Buy on ReadyTech Holdings Ltd. (RDY)

TIPRANKS
·
04 Mar

Is Dr. Reddy’s Laboratories Limited (RDY) the Best Weight Loss Drug Stock to Buy According to Analysts?

Insider Monkey
·
02 Mar

ReadyTech Holdings First Half 2025 Earnings: AU$0.16 loss per share (vs AU$0.018 profit in 1H 2024)

Simply Wall St.
·
01 Mar

Macquarie downgrades ReadyTech Holdings Ltd. (RDY) to a Hold

TIPRANKS
·
28 Feb

Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading

MT Newswires Live
·
27 Feb

Is Dr. Reddy’s Laboratories Limited (RDY) the Best Low Price Pharma Stock to Invest In Right Now?

Insider Monkey
·
27 Feb